Neuronetics
Manufacturing · Pennsylvania, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
3222 Phoenixville Pike, Malvern, Pennsyl...Phone Number
(877) 600-7555Website
www.neurostar.comRevenue
$151.6 MillionStock Symbol
STIMIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
1
1
1
1
1
About Neuronetics
Neuronetics NeuroStar Advanced Therapy for Mental Health is todays leading TMS (transcranial magnetic stimulation) treatment and is backed by more clinical evidence than any other TMS technology for depression. The largest TMS company in the industry, NeuroStar helps practices succeed by providing exceptional ongoing support. The company is headquartered in Malvern, Pennsylvania.Explore more
Neuronetics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neuronetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Neuronetics launches new products
Check out if Neuronetics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Neuronetics has new funding data
Earning: See what the market has to say on Neuronetics recently announced quarterly report
Neuronetics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Neuronetics
Check if Neuronetics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Neuronetics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Neuronetics
Find 2 more new buyers
Compare Similar Companies to Neuronetics
Compare insights from companies similar to Neuronetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neuronetics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neuronetics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neuronetics.
Neuronetics financials insights
Gather financial insights about Neuronetics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series E
$30M
2023
Debt
$60M
Neuronetics Tech Stack
A closer look at the technologies used by Neuronetics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Earnings, Forecasting, Financial Reporting, Finance
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Neuronetics News & Media
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
New location expands access to advanced mental health treatments while serving as Greenbrook's flagship innovation center and blueprint for future care delivery New location expands access to advanced mental health treatments while serving as Greenbrook's flagship innovation center and blueprint for future care deliveryNeuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that it plans to release second quarter 2026 financial and operating results prior to market open on Tuesday, August 11, 2026. The Company will host a conference call to review its results at 8:30 a.m. Eastern TimeNeuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes
MALVERN, Pa., July 20, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be appointed Chief Financial Officer effective July 23, 2026. "Nir is a proven leader who brings the financial discipline and rigor our strategy demands," said Dan Reuvers, President and Chief Executive ONeuronetics (STIM) to Present at B. Riley Mind, Muscle & Vision Summit
Neuronetics, Inc. (NASDAQ:STIM) is one of the 10 High Growth Stocks Insiders Are Buying. On July 6, 2026, Neuronetics, Inc. (NASDAQ:STIM) announced that management will participate at B. Riley Securities’ Mind, Muscle & Vision Summit, an invitation-only institutional investor event being held in person at the InterContinental Boston. Neuronetics will participate in a panel discussion titled […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neuronetics
Sign Up For FreeTo access detailed company insights
Neuronetics NeuroStar Advanced Therapy for Mental Health is todays leading TMS (transcranial magnetic stimulation) treatment and is backed by more clinical evidence than any other TMS technology for depression. The largest TMS company in the industry, NeuroStar helps practices succeed by providing exceptional ongoing support. The company is headqua... Read More
